Nucleai, an AI-powered spatial biology leader, announced that Dr. Julian Adams has joined its scientific advisory board. Dr. Adams brings his more than 35 years of experience in oncology research and development to his role as an advisor to Nucleai, which is recognized as one of the top startups to watch in the spatial biology field. His distinguished career in the pharmaceutical and biopharmaceutical industry includes senior leadership roles at Millennium Pharmaceuticals (now part of Takeda Oncology), Infinity Pharmaceuticals, Boehringer Ingelheim, and Gamida Cell.